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Abstract 
 American Association of Individual Investors (AAII) provides stock screens that follow 
the investment strategies of some of the most well-known investors. This paper uses Carhart 
four-factor model and adjusts returns for transaction costs to see whether these portfolios 
generate abnormal returns. I find that the number of portfolios with excess returns significantly 
decreases under the restrictions of the four-factor model and transaction costs assumptions. In 
addition, I find that momentum is a statistically significant factor in explaining the returns of 
these portfolios. The results of this study suggest that markets are inefficient in the weakest form, 
since information about the past price trends can be used to generate abnormal returns.   
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I. Introduction 
Over the past fifty years, much of the research in finance has focused on asset-pricing 
models and the existence of abnormal returns for a well-diversified portfolio. As a result, three 
well-known models have emerged: Capital Asset Pricing Model (CAPM), Fama-French three-
factor Model, and Carhart four-factor model. Although both CAPM and Fama-French models 
have been widely applied around the world, these models have failed to explain abnormal returns 
that famous investors such as Warren Buffett and Peter Lynch are able to generate. Can 
individual investors outperform the market using the strategies of some of the most successful 
investors? The American Association of Individual Investors (AAII) is a non-profit organization 
that provides educational resources for individual investors. The creators of the association have 
developed stock screens that follow successful investment strategies of more than 50 well-known 
investors. AAII claims that its model portfolios outperform the market 5-to-1.  
When it comes to active trading, individual investors are often at a disadvantage. Unlike 
big fund managers, they do not have access to the same informational resources. Due to the high 
transaction costs, gains from active trading tend to be low for individual investors, and they often 
end up holding a broadly diversified index fund.  Stock screens from AAII could give small 
investors an opportunity to engage in active trading. For an annual fee of $29 one can have the 
access to about 60 different stock screens and learn about number of different styles and 
methodologies used by famous investors. Another advantage of AAII stock portfolios is that they 
are machine-generated and are thus free of psychological biases that individual investors face.  
 This study examines whether using AAII stock screens is a good investment practice. I 
look at the historical performance of the AAII stock screen-generated portfolios and use three 
different asset pricing models to determine whether these portfolios have been able to generate 
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abnormal returns. I find that when I use the Carhart four-factor model and adjust the individual 
portfolio returns for transaction costs, the number of portfolios that generate abnormal returns 
significantly decreases.  
  
II. Prior Studies 
This study has implications for three areas in finance. It contributes to the study of overall 
market efficiency, behavioral finance, and investment strategies. Individuals have to make a 
choice between passive and active investing. Their choice depends on whether they believe that 
markets are efficient or not. Market efficiency theory suggests that current stock price “fully 
reflects” all the available information and one cannot expect to generate excess returns on a risk-
adjusted basis. Fama (1970) discusses three forms of inefficiency. He argues that markets are 
efficient in a weak form if the current stock price already reflects the historical prices and the 
return trends. This form of efficiency suggests that one cannot use technical analysis to generate 
excess future returns. Semi-strong form efficiency suggests that all publicly available information 
is fully priced. Therefore, investors can use neither technical nor fundamental analysis to 
outperform the market index. Markets are efficient in a strong form if share prices fully reflect 
both public and private information. This form of efficiency suggests that even if you are a 
corporate insider and have access to confidential information, you cannot expect to beat the 
market. Thus, active investors believe that markets are inefficient, and they constantly monitor 
price movements to exploit any discrepancy from the stock’s actual value. On the other hand, 
passive investors will generally hold a broadly-diversified market index fund and hope for long-
term price appreciation. Malkiel (2003) argues that even if markets are efficient, passive 
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investment strategy still outperforms the active investment strategy because of the high 
transaction costs involved in active trading.  
The market efficiency hypothesis assumes that investors are rational, utility-maximizers 
not prone to any psychological biases. However, studies such as Kahneman and Tversky (1979) 
and DeBondt and Thaler (1985) have shown that investors tend to value gains and losses 
differently and overreact to unexpected news. Jegadeesh and Titman (1993) and Greenblatt, 
Titman, and Wermers (1995) find that stocks and mutual funds tend to exhibit momentum. This 
can be explained through herding behavior or the tendency of individuals to mimic behaviors of 
others. Such findings have led to the emergence of behavioral finance. Proponents of behavioral 
finance believe that stock prices reflect the beliefs and decisions of both rational and irrational 
investors (Hirshleifer, 2001). Thus, inefficiencies in the financial markets are caused by 
psychological biases.  
Behavioral finance suggests that rational investors can earn excess returns exploiting the 
inefficiencies created by irrational investors. A number of studies have looked at different 
investment practices and individual stock-picking skills. Barber, Lehavy, McNichols and 
Trueman (2001) find that purchasing stocks with the most favorable consensus recommendations 
leads to abnormal returns. However, they argue that frequent trading is necessary to generate 
such returns, which increases the transaction costs.  On the other hand, Metrick (1998) examines 
the equity-portfolio recommendations made by investment newsletters and argues that they do 
not show superior stock picking abilities. Schadler and Cotten (2008) analyze the performance of 
AAII screens and find that 32% of the portfolios successfully beat the S&P 500 when they use a 
one-factor model and adjust for transaction costs. A working paper by North and Stevens (2013) 
extends the study by Schadler and Cotten by using a three-factor model. They find that number 
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of portfolios that are able to generate abnormal returns far exceed what pure chance would have 
predicted. I extend studies done by Schadler and Cotten and North and Stevens by using a four-
factor model to measure the performance of the AAII portfolios.  
 
III. Methodology  
I use different methodologies to see how AAII portfolios perform compared to the market. 
I use index comparisons, Sharpe and Sortino ratios, and three different asset-pricing models. In 
addition, I adjust the returns for transaction costs.  
 
Index Comparisons 
 To see whether AAII portfolios are able to outperform the market on average, I use the 
S&P 500 as a benchmark index. However, because these portfolios differ based on their 
strategies and size of the stocks held, other indices such as S&P Midcap 400 or S&P Smallcap 
600 might be a better fit. To find the best-fit indices, I use the indices whose returns most highly 
correlate with the portfolio returns in question. This is the method used by Schadler and Cotton 
(2008). 
 
Sharpe and Sortino Ratios 
 The Sharpe ratio is a risk-to-reward ratio that William Sharpe first introduced in 1966 to 
measure the mutual fund performance. It measures the expected return per unit of risk and can be 
calculated as follows:  
(1)                                                                          𝑟𝑝 −𝑟𝑓
𝜎𝑝
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where rp is the portfolio return, rf  is the risk-free rate, and 𝜎𝑝 is the standard deviation that 
reflects the volatility of the portfolio. The higher the Sharpe ratio, the higher the expected return 
for a given level of risk.  
The standard deviation term in the Sharpe ratio treats both upside and downside 
deviations equally, but high upside deviation is good for investors because it translates into 
higher returns. The Sortino ratio considers this fact and breaks down the standard deviation into 
upside and downside deviations. The simple Sortino ratio can be calculated as follows:  
(2)                                                             𝜎𝑢𝑝𝑠𝑖𝑑𝑒
𝜎𝑑𝑜𝑤𝑛𝑠𝑖𝑑𝑒
  
If this ratio is more than one, then the portfolio has more upside deviation and therefore offers 
more downside risk protection.  
 
Jensen’s Alpha  
 Jensen’s alpha, which Michael Jensen introduced in 1967, is widely used to measure 
portfolio performance. It is an excess return over the return that the asset-pricing models predict. 
If markets are efficient, Jensen’s alpha should be equal to zero. Thus, finding a positive value for 
alpha suggests that a manager has superior stock-picking abilities. Obtaining an accurate value 
for Jensen’s alpha requires a reliable asset-pricing model.  
 
Asset-pricing Models 
Asset-pricing models are well established in the finance literature. The Capital Asset 
Pricing Model (CAPM) is probably the most important topic taught in introductory finance 
course. CAPM, which was developed by Jack Treynor (1962),William Sharpe (1964), John 
Lintner (1965a,b) and Jan Mossin (1966) independently, is the simplest way to determine a 
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theoretical required rate of return on an asset.  It allows investors to calculate a risk-to-reward 
ratio based on a security’s sensitivity to the expected market return. Portfolio performance 
relative to CAPM can be estimated as follows:  
(3)                                                     (rpi  -rf) = α + β1(rm-rf) + µ 
where rpi is a return on portfolio i generated by AAII, rf  is a risk-free rate assumed to be one-
month treasury bill return, and (rm-rf) is a market risk premium. The constant term, α, is the 
Jensen’s alpha. If α is statistically significant, it would mean that AAII portfolios are able to 
generate excess returns.  
 CAPM often indicates statistically significant returns for portfolio managers. Many 
researchers argue that this happens because other risk factors have not been included. Over the 
years, researchers have found factors that explain average stock returns better than CAPM. For 
example, DeBondt and Thaler (1985) find that stock returns tend to reverse in the long-run and 
portfolios of prior “losers” outperform the prior “winners.” Jegadeesh and Titman (1993) find 
that in the short-run stocks tend to exhibit momentum. Thus, the strategy of buying past winners 
and selling past losers leads to significant abnormal returns. On the other hand, some have 
concluded that size, earnings/price, cash flow/price, and book to market value ratios are 
important variables in explaining returns. Such criticisms have led to the emergence of new 
models. The Fama-French three-factor and Carhart four-factor models are the most popular.  
Fama and French (1996) argue that three factors explain most of the anomalies. Their 
model extends CAPM by adding size and value factors. Performance can be estimated as follows:  
(4)                                    (rpi-rf) = α + β1(rm-rf) + β2(SMB) + β3(HML) + µ 
where SMB is a size premium, measured as a difference between the return on stocks with 
relatively small market capitalization and the return on stocks with large capitalization. HML is a 
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value premium, measured as a difference between the returns on stocks with high book-to-
market ratio (value) and stocks with low book-to-market ratio (growth).  
Fama and French (1993) argue that the size of the firm is related to profitability. Smaller 
firms usually have lower earnings than big firms. Thus, the size premium is a risk premium for 
the possibility of receiving lower average returns. However, one can also argue that there is more 
“inefficiency” in small-caps. Unlike small-caps, large-cap stocks tend to be well covered by the 
Wall Street analysts. Stock reports are regularly updated and published on research databases. 
An investor can find numerous reports about a single large-cap stock with up-to-date information 
and make informed decisions. However, many analysts tend to overlook small-caps, and there 
are fewer reports available on them. Although small-caps have become more liquid over the last 
few years, they are still more thinly traded than the large-caps. Because of these inefficiencies, a 
rational investor requires a higher return when investing in smaller-caps. 
 HML is a difference between the returns on stocks with high book-to-market ratio (value) 
and stocks with low book-to-market ratio (growth). A high book-to-market ratio is often 
associated with weak firms that have persistently low earnings, whereas low book-to-market 
ratios are typical of strong companies with high earnings. Thus, HML is a risk premium related 
to the possibility of financial distress. However, HML could be capturing an inefficiency. The 
stock market often overreacts to good and bad news, resulting in a price that does not reflect the 
true value of the company based on its long-term fundamentals. Once the price adjusts to the 
actual value, investors that bought the stock when it was undervalued are able to earn higher 
returns.  
Another model and the main focus of this study is Carhart four-factor model (1997). 
Carhart (1997) finds that the momentum factor first introduced by Jegadeesh and Titman (1993) 
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explains the persistence of high returns for mutual funds. His four-factor model is constructed by 
adding a one-year momentum factor to the Fama-French three-factor model. Performance 
relative to Carhart’s model can be estimated as follows:  
(5)                  (rpi-rf) = α + β1(rm-rf) + β2(SMB) + β3(HML) + β4(MOM) + µ 
The momentum factor (MOM) describes the tendency of rising stock prices to continue 
rising and falling prices to continue falling. Thus, if an investor buys a stock whose price has 
been on the rise recently, and if other investors follow, the mere belief that the stock price will 
continue to rise will lead to the actual price increase. The momentum factor suggests that smart 
investors who are able to predict which stocks will become “Wall Street Darlings” will be able to 
earn high profits. Momentum is not a risk premium, but a pure anomaly. There is no reason why 
an increase in a stock price should, by itself, lead to further price appreciation. According to 
behavioral finance theorists, momentum in a stock is the result of investor herding. If markets are 
efficient, the coefficient, β4, on the momentum factor should not be statistically significant. We 
should not be able to use the information about past price trends and expect to generate profits. If 
this study finds that the momentum factor helps explain the returns, we can argue that markets 
are inefficient in the weakest form. Including the momentum factor in the model controls for 
some of the behavioral inefficiencies. 
Carhart four-factor model has been widely applied to mutual fund performances and 
stock market returns in international financial markets. Fama and French (2011) apply Carhart 
four-factor model to the stock markets in North America, Europe, Japan and Asia Pacific and 
find statistically significant value and momentum premium in all of the markets except for Japan. 
Fletcher (2012) finds that Carhart’s conditional four-factor model is the most reliable model to 
explain expected returns on the U.K. portfolio. Cakici, Fabozzi and Tan (2013) apply asset-
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pricing models to the emerging markets and find strong value and momentum effects in all of the 
regions except Eastern Europe. L’Her, Masmoudi, and Suret (2004) apply Carhart four-factor 
model to the Canadian Stock Market and find that momentum factor returns are significant 
throughout the year, while size and value premiums vary. These studies suggest that a 
comprehensive asset-pricing model must account for market risk, size, value, and momentum.  
 
Transaction Costs 
 The transaction costs associated with trading can have a significant effect on the returns, 
especially for small investors. To have an accurate measure of portfolio returns, it is important to 
control for transaction costs. I follow Schadler and Cotten (2008) and North and Stevens (2013) 
to adjust for transaction costs. I assume a 100% turnover rate. This means that there are two 
trades per month; all the stocks in the portfolio are bought at the beginning of the month and all 
of them are sold at the end of the month. In fact, the turnover rate is about 40% for the AAII 
portfolios, but because of the data that are available I am limited to a 100% turnover rate. Like 
Schadler and Cotten and North and Stevens, I assume a $7 fee per trade. Transaction costs are 
calculated as:  
(6) $ transaction costs = ($7)(2)(# of stocks in the portfolio) 
Since transaction costs will be a higher percentage of the initial investment when the initial 
investment is small, the size of the initial investment will impact the percentage returns. I am 
assuming an initial investment of $50,000, similar to the amount used by Schadler and Cotten in 
their study. Since AAII portfolios are mostly for small investors, I want to see how the portfolios 
perform net of the transaction costs, when the size of the initial investment is relatively small. 
The returns can be calculated using the following formula:  
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(7) radjusted = $50,000 (1+rpi) - $ transaction costs$50,000  - 1  
where radjusted is the portfolio return after the transaction costs and rpi is the portfolio return before 
the adjustment is made. I adjust the returns of only those portfolios that are able to generate 
statistically significant Jensen’s alphas under the four-factor model.  
 If the AAII portfolios generate statistically significant abnormal returns under the strict 
restrictions of the four-factor model and after introducing transaction costs, then using AAII 
screens will be a good investment practice. Furthermore, the investors whose strategies these 
screens are using arguably possess superior skills.  
 
IV. Data 
Data used in this study come from the American Association of Individual Investors 
(AAII). AAII is a non-profit association that offers educational materials to individual investors. 
AAII provides stock screens that reflect interpretations of the investment approaches advocated 
by successful strategists. Historical performance of the computer-generated portfolios is publicly 
available on AAII’s website (www.aaii.com). Data used for this study provide monthly price 
change for a total of 84 portfolios spanning the period from January 1998 through October 2013.  
Of these 84 portfolios, 16 are stock market indices, one is the Treasury Bill Index and one is the 
exchange-listed stock portfolio. Since indices do not involve picking any stocks, they cannot be 
used for the study. This leaves me with 66 portfolios for the purposes of this study. Sample 
portfolios include value, growth, growth/value, and specialty/sector portfolios. The number of 
portfolios that can be classified under each strategy are presented in Table 1.1
1 For complete summary statistics see Appendix I.  
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Table 1. Investment Strategies and Number of Portfolios Using Each Strategy 
Investment Strategy Growth Value 
Growth and 
Value 
Growth with 
Price 
Momentum 
Value with 
Price 
Momentum 
Growth and 
Value with 
Price 
Momentum 
Earnings 
Estimate Specialty All Strategies 
Number of Portfolios 4 15 21 6 6 7 6 1 66
% of the Total Sample 6% 23% 32% 9% 9% 11% 9% 2% 100%
Table 2. Summary Statistics for AAII Portfolios 
Growth 
(n=4)
Value 
(n=15)
Growth 
and Value 
(n=21)
Growth 
with Price 
Momentum 
(n=6)
Value with 
Price 
Momentum 
(n=6)
Growth 
and Value 
with Price 
Momentum 
(n=7)
Earnings 
Estimate 
(n=6)
Specialty 
(n=1)
All 
Strategies 
(n=66)
MMR > S&P 4 14 21 6 6 7 6 0 64 (97%)
Average difference 0.69% 1.02% 0.76% 1.24% 1.07% 0.97% 1.04% -0.14%
GMMR > S&P 4 13 20 6 6 6 4 0 59 (89%)
Average difference 0.61% 0.85% 0.61% 0.97% 0.95% 0.69% 0.81% -0.36%
MMR > Best Fit Index 4 15 20 6 6 7 6 0 64 (97%)
Average difference 0.92% 1.16% 0.92% 1.28% 1.26% 1.00% 1.12% -0.05%
GMMR > Best Fit Index 3 11 18 6 5 6 4 0 53 (80%)
Average difference 0.60% 0.58% 0.32% 0.70% 0.61% 0.50% 0.51% -0.77%
Note: MMR stands for arithmetic mean monthly return and GMMR stands for geometric mean monthly return. Differences are calculated 
over the period 1998-2013.
12 
 
Market risk, size, value and momentum premiums are obtained from Kenneth French’s 
website. Market risk premium is the excess return above the risk-free rate (rm-rf). Market return 
is found as a return on all firms that are listed on NYSE, AMEX, and NASDAQ, and one-month 
Treasury bill rate is used as a risk-free rate. Size premium is based on the performance of small-
cap stocks relative to large-cap stocks (SMB, rsmall-rbig). Fama and French calculate this factor by 
creating portfolios based on their size and by subtracting the average return on the three large-
cap portfolios from the average return on the three small-cap portfolios. The value premium is 
determined as the performance of value stocks relative to growth stocks (HML, rhigh-rlow). It is 
calculated as the difference between the average return on the two value portfolios and the two 
growth portfolios. Fama-French momentum factor is constructed as the average of the returns on 
two high-prior-return portfolios minus the average of the returns on two low-prior-return 
portfolios. Fama-French benchmark factors are widely used when explaining returns using the 
three-factor model. These benchmark returns are updated every month and cover the period from 
July 1926 through October 2013.2 
 To measure the returns on the AAII portfolios, the risk-free rate must be subtracted from 
the actual portfolio returns. Following Fama and French, I use one-month Treasury bill rate as a 
risk-free rate. One-month Treasury bill rates can also be obtained from the Kenneth French’s 
website. 
 
V. Empirical Results  
I analyze the performance of 66 AAII portfolios using the methodologies described in 
Section III. I first look at the performance relative to the S&P 500 and best-fit indices. Table 2 
2 Complete information on the four factors can be found on Kenneth French’s website.  
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shows portfolios under each strategy that were able to outperform the S&P 500 and their best-fit 
index. Based on the arithmetic mean of monthly returns over the measurement period, 64 out of 
the 66 portfolios were able to beat the S&P 500 and their best-fit index. In addition to arithmetic 
mean returns, I also look at the differences between the geometric mean returns. Geometric mean 
return tells an investor what the average compounded rate of return would be if the portfolio was 
held during the entire measurement period. Based on the geometric mean monthly returns, I find 
that 59 of the portfolios beat the S&P and 54 of the portfolios beat their best-fit index. Overall, 
based on both arithmetic and geometric averages, 80-97% of portfolios outperform the market. 
This result is close to the 91% that AAII reports.  
Next, I use Sharpe and Sortino ratios to compare AAII portfolios to the S&P 500. The 
Sharpe and Sortino ratios for S&P 500 are 0.05 and 0.70, respectively. Fifty-seven of the AAII 
portfolios have a Sharpe ratio higher than 0.05 and 63 have Sortino ratios higher than 0.70. 
Based on these ratios, AAII portfolios offer higher reward for the given level of risk compared to 
the S&P 500. Most of these portfolios also offer more upside potential than the S&P 500.  
To see whether AAII portfolios generate statistically significant abnormal returns on the 
risk-adjusted basis, I run separate regressions for all 66 portfolios using CAPM, Fama-French 
three-factor model and Carhart four-factor model without adjusting for transaction costs. Table 3 
shows the main findings of the regression analysis.3 Under CAPM, 59% of the portfolios 
generate statistically significant abnormal returns. Using the three-factor model the percentage of 
portfolios with statistically significant abnormal returns decreases to 48%. Only 39% of the 
portfolios generate excess returns under Carhart four-factor model. The adjusted R2 increases 
moving from one-factor to three-factor and four-factor models. I find that Carhart four-factor 
model has the highest explanatory power. In addition, top portfolios that are able to generate 
3 Detailed regression results are reported in the Appendix  
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Table 3. Number of Portfolios with Statistically Significant Positive Alphas 
Growth 
(n=4)
Value 
(n=15)
Growth 
and Value 
(n=21)
Growth 
with Price 
Momentum 
(n=6)
Value with 
Price 
Momentum 
(n=6)
Growth 
and Value 
with Price 
Momentum 
(n=7)
Earnings 
Estimate 
(n=6)
Specialty 
(n=1)
All 
Strategies 
(n=66)
CAPM
Three Factor 
Four Factor 
Four Factor Adjusted for 
Transaction Costs 
0 3 0 1 0 1 0 0 5 (8%)
3 8 0435412
227
39 (59%)
04344
71 3
63 32 (48%)8
4 0 26 (39%)
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 Table 4. Number of Portfolios with Statistically Significant Momentum Factor 
Investment Strategy Growth Value Growth and 
Value 
Growth with 
Price 
Momentum 
Value with 
Price 
Momentum 
Growth and 
Value with 
Price 
Momentum 
Earnings 
Estimate 
Specialty All Strategies 
Number of Portfolios with 
Significant Positive 
Momentum 
2 2 9 5 6 4 2 0 30
Portfolios with Positive 
Momentum as a % of Total 
Number of Portfolios in the 
Strategy 
50% 13% 43% 83% 100% 57% 33% 0% 45%
Number of Portfolios with 
Significant Negative 
Momentum 
0 1 5 0 0 0 2 0 8
Portfolios with Negative 
Momentum as a % of Total 
Number of Portfolios in the 
Strategy 
0% 7% 24% 0% 0% 0% 33% 0% 12%
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statistically significant abnormal returns under CAPM are top portfolios under three-factor and 
four-factor models as well.  
Thirty of the 66 portfolios have statistically significant positive coefficients on the 
momentum factor and only 8 of the portfolios have statistically significant negative coefficients. 
This finding suggests the existence of market inefficiencies. AAII portfolios are apparently using 
information about the past price trends to generate returns. This should not be happening if 
markets are efficient in the weakest form. According to the proponents of behavioral finance, 
momentum is a result of investor herding. Since investor herding is a behavioral bias, the 
positive coefficient on the momentum factor suggests that although AAII portfolios are 
computer-generated, they are not completely free of behavioral biases. Therefore, the users of 
AAII portfolios are still somewhat subject to the cognitive biases that many investors face.  
Finding statistically significant positive coefficient on the momentum factor also suggests 
that the investors whose strategies are adopted in the AAII screens are exploiting behavioral 
inefficiencies. We hear stories about how these successful investors have a market insight and 
know exactly which stocks are going to perform well. However, it appears that their insight lies 
in exploiting the behavioral inefficiencies in the market.  
Next, I look at the portfolios that generated statistically significant abnormal returns 
under the four-factor model and adjust the returns for transaction costs using the methodology 
outlined in Section III. After introducing the transaction costs, only 5 portfolios generate 
statistically significant abnormal returns. Compared to the rest of the portfolios, these five 
portfolios have the lowest adjusted R2s. Therefore, it is possible that these five portfolios use 
strategies different from what the models are controlling for. There is also a possibility that the 
returns on the rest of the portfolios were artificially low due to the high turnover rate assumption. 
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In reality, investors do not liquidate their entire portfolios every month, and therefore their 
transaction costs are much lower. It is possible that less actively traded AAII portfolios generate 
statistically significant abnormal returns with lower transaction costs.   
VI. Conclusions  
 This study analyzes the performance of AAII stock screen-generated portfolios during the 
period from 1998 to 2013. The majority of the portfolios beat the S&P 500 and their best-fit 
indices based on arithmetic and geometric average monthly returns without adjusting for 
transaction costs. In addition, AAII portfolios offer better risk-to-reward ratios and more upside 
potential than S&P 500.  
 Out of the three different factor models used, Carhart four-factor model has the highest 
explanatory power. Even under the strictest restrictions of the four-factor model, 26 out of 66 
AAII portfolios generate statistically significant abnormal returns. However, once transaction 
costs are included in the four-factor model, this number decreases to just 5. Thus, the claim that 
91% of the portfolios outperform the market is invalid. In addition, this study finds that 
momentum is an important factor in explaining returns. About 45% of the AAII portfolios have a 
statistically significant positive coefficient on the momentum.  
 The findings of this study suggest that markets are inefficient in the weakest form. We 
should not be able to use information about the past returns to earn abnormal returns; however, a 
positive coefficient on the momentum can account for this possibility. Only five portfolios 
generate statistically significant abnormal returns after I introduce the momentum factor and 
transaction costs. This suggests that these portfolios use unique strategies not captured by the 
factors in the model. Although AAII portfolios are computer-generated and are supposed to be 
free of behavioral biases, the positive coefficient on the momentum factor suggests otherwise. I 
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conclude that using AAII stock screens is a good investment practice in the absence of high 
transaction costs. However, one would not be able to randomly pick one of the AAII portfolios 
and expect to generate abnormal returns after adjusting for transaction costs. Further studies 
could examine how different turnover rates and holding periods affect the performance of the 
AAII portfolios.  
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Appendix I. Summary Statistics  
 
Table 1. Summary Statistics 
Variables Strategy 
Number 
of Stocks 
Held 
N Min. Max.
Arithmetic 
Mean 
Geometric 
Mean
Std. 
Deviation
Sharpe 
Ratio σup/σdown
Arithmetic  
(rp-rS&P)
Geometric 
(rp-rS&P)
Arithmetic 
(rp-rbest fit)
Geometric 
(rp-rbest fit)
O'Shaughnessy Tiny Titans Value/Price MOM 25 190 -21.42% 37.12% 2.11% 1.92% 8.89% 0.22 0.96 1.89% 1.61% 1.92% 1.26%
O'Shaughnessy Small Cap Growth and Value Value/Price MOM 25 190 -18.60% 18.40% 1.56% 1.51% 6.97% 0.20 0.79 1.33% 1.20% 1.51% 0.95%
O'Shaughnessy Growth Value/Price MOM 50 190 -18.34% 18.50% 1.39% 1.34% 6.96% 0.17 0.73 1.16% 1.03% 1.34% 0.75%
Lakonishok Value/Price MOM 31 190 -17.98% 16.24% 1.09% 1.14% 5.54% 0.16 0.84 0.87% 0.83% 1.14% 0.42%
O'Shaughnessy All Cap Value/Price MOM 22 190 -21.61% 18.40% 1.03% 1.02% 6.33% 0.13 0.81 0.80% 0.71% 1.02% 0.40%
O'Shaughnessy Growth Market Leaders Value/Price MOM 10 190 -18.78% 13.19% 0.57% 0.61% 5.61% 0.07 0.77 0.34% 0.30% 0.61% -0.11%
Piotroski: 9 Value 9 190 -29.65% 61.80% 3.19% 2.83% 11.20% 0.27 1.96 2.97% 2.52% 2.83% 2.34%
Piotroski High F-Score Value 21 190 -42.01% 43.12% 2.57% 2.31% 9.55% 0.25 1.08 2.34% 2.00% 2.31% 1.72%
Graham Enterprising Investor Revised Value 9 190 -22.38% 36.43% 1.76% 1.65% 8.01% 0.20 1.22 1.54% 1.34% 1.65% 1.09%
Price-to-Free Cash Flow Value 30 190 -31.81% 51.19% 1.70% 1.57% 8.21% 0.18 1.19 1.48% 1.26% 1.57% 1.07%
Graham Enterprising Investor Value 4 190 -23.46% 33.06% 1.51% 1.39% 8.06% 0.16 1.32 1.28% 1.08% 1.39% 0.90%
Weiss Blue Chip Div. Yield Value 12 190 -16.89% 15.95% 0.84% 0.88% 5.62% 0.12 0.89 0.62% 0.57% 0.88% 0.21%
Graham Defensive Investor Non-Utility Value 21 190 -17.34% 25.83% 1.42% 1.41% 6.33% 0.19 0.92 1.19% 1.10% 1.41% 0.79%
Fundamental Rule of Thumb Value 50 190 -19.60% 33.28% 1.22% 1.12% 7.85% 0.13 1.20 1.00% 0.81% 1.12% 0.58%
Cash Rich Firms Value 30 190 -21.14% 17.14% 0.89% 0.88% 6.34% 0.11 0.79 0.67% 0.57% 0.88% 0.04%
Schloss Value 12 190 -40.49% 26.56% 1.10% 0.93% 8.48% 0.11 1.01 0.88% 0.62% 0.93% 0.25%
Magic Formula Value 30 190 -22.51% 30.70% 0.97% 0.88% 7.61% 0.10 1.07 0.75% 0.57% 0.88% 0.12%
Graham Defensive Investor Utility Value 19 190 -13.41% 11.49% 0.54% 0.65% 4.16% 0.08 0.80 0.32% 0.34% 0.65% -0.09%
O'Shaughnessy Value Value 50 190 -23.84% 22.01% 0.48% 0.48% 6.20% 0.05 0.84 0.25% 0.17% 0.48% -0.16%
Dogs of the Dow LowPriced 5 Value 5 190 -34.80% 27.61% 0.25% 0.16% 7.31% 0.01 0.79 0.02% -0.15% 0.16% -0.02%
Dogs of the Dow Value 10 190 -23.39% 17.07% 0.19% 0.22% 5.65% 0.00 0.77 -0.04% -0.09% 0.22% -0.08%
Insider Net Purchases Specialty 28 190 -27.27% 27.77% 0.08% -0.05% 8.12% -0.01 0.95 -0.14% -0.36% -0.05% -0.77%
Value on the Move PEG With Est. Growth Growth/Value/Price MOM 40 190 -23.49% 15.23% 1.53% 1.54% 6.12% 0.22 0.71 1.31% 1.23% 1.54% 0.89%
Stock Market Winners Growth/Value/Price MOM 12 190 -23.51% 21.97% 1.66% 1.63% 6.79% 0.22 0.95 1.43% 1.32% 1.63% 0.98%
Value on the Move PEG With Hist. Growth Growth/Value/Price MOM 80 190 -19.56% 12.29% 1.07% 1.15% 4.80% 0.18 0.62 0.85% 0.84% 1.15% 0.43%
MAGNET Simple Growth/Value/Price MOM 3 190 -33.99% 51.79% 2.08% 1.37% 13.83% 0.14 1.48 1.85% 1.06% 1.37% 1.40%
Oberweis Octagon Growth/Value/Price MOM 16 190 -23.62% 24.60% 1.32% 1.13% 8.83% 0.13 0.95 1.10% 0.82% 1.13% 0.65%
MAGNET Complex Growth/Value/Price MOM 2 190 -28.21% 62.67% 1.46% 0.93% 12.50% 0.10 1.79 1.24% 0.62% 0.93% 0.69%
Muhlenkam Growth/Value/Price MOM 18 190 -18.03% 20.94% 0.32% 0.31% 6.44% 0.02 0.76 0.10% 0.00% 0.31% -0.28%
Zweig Growth/Value 11 190 -24.66% 32.21% 1.63% 1.49% 8.26% 0.17 1.19 1.40% 1.18% 1.49% 0.99%
Shadow Stock Screen Growth/Value N/A 190 -21.48% 27.85% 1.20% 1.21% 6.22% 0.16 1.24 0.98% 0.90% 1.21% 0.57%
Templeton Growth/Value 22 190 -23.16% 14.50% 0.85% 0.88% 5.71% 0.12 0.68 0.63% 0.57% 0.88% 0.18%
Rule #1 Investing Growth/Value 14 190 -26.95% 26.44% 1.14% 0.99% 8.18% 0.12 0.90 0.91% 0.68% 0.99% 0.28%
T. Rowe Growth/Value 8 190 -20.01% 33.50% 0.93% 0.83% 7.76% 0.09 1.28 0.70% 0.52% 0.83% 0.29%
Wanger Revised Growth/Value 30 190 -20.18% 22.37% 0.80% 0.77% 6.61% 0.09 0.88 0.57% 0.46% 0.77% 0.16%
Murphy Technology Growth/Value 11 190 -44.97% 58.46% 0.49% -0.13% 12.78% 0.02 1.11 0.26% -0.44% -0.13% -0.37%
Neff Growth/Value 22 190 -21.73% 32.56% 1.66% 1.57% 7.53% 0.19 1.10 1.43% 1.26% 1.57% 1.02%
Buffett: Hagstrom Growth/Value 30 190 -19.05% 12.68% 1.11% 1.18% 5.12% 0.18 0.77 0.89% 0.87% 1.18% 0.89%
Price-to-Sales Growth/Value 55 190 -20.66% 18.31% 1.23% 1.24% 6.09% 0.17 0.72 1.00% 0.93% 1.24% 0.38%
Dividend Screen Non-DRP Growth/Value 30 190 -15.39% 17.58% 0.89% 0.99% 4.33% 0.16 0.75 0.66% 0.68% 0.99% 0.26%
Lynch Growth/Value 25 190 -21.35% 18.79% 0.98% 1.02% 5.65% 0.14 0.93 0.76% 0.71% 1.02% 0.37%
Foolish Small Cap 8 Revised Growth/Value 6 190 -31.10% 27.71% 1.49% 1.20% 9.92% 0.13 1.08 1.27% 0.89% 1.20% 0.73%
Buffettology: Sustainable Growth Growth/Value 33 190 -20.46% 16.07% 0.91% 0.93% 5.91% 0.12 0.83 0.68% 0.62% 0.93% 0.23%
Buffettology: EPS Growth Growth/Value 47 190 -20.87% 15.09% 0.86% 0.89% 5.63% 0.12 0.72 0.64% 0.58% 0.89% 0.19%
Dreman Growth/Value 21 190 -22.25% 23.85% 0.84% 0.87% 5.78% 0.11 0.80 0.62% 0.56% 0.87% 0.21%
Kirkpatrick Value Growth/Value 2 190 -25.30% 49.00% 1.22% 0.95% 9.87% 0.10 1.47 0.99% 0.64% 0.95% 0.54%
Dividend (High Relative Yield) Growth/Value 40 190 -14.38% 12.20% 0.64% 0.74% 4.44% 0.10 0.76 0.42% 0.43% 0.74% 0.01%
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Table 1 (continued)
Variables Strategy 
Number 
of Stocks 
Held 
N Min. Max.
Arithmetic 
Mean 
Geometric 
Mean
Std. 
Deviation
Sharpe 
Ratio σup/σdown
Arithmetic  
(rp-rS&P)
Geometric 
(rp-rS&P)
Arithmetic 
(rp-rbest fit)
Geometric 
(rp-rbest fit)
Dividend Screen DRP Growth/Value 30 190 -18.33% 20.51% 0.60% 0.67% 5.10% 0.08 0.86 0.38% 0.36% 0.67% -0.03%
Kirkpatrick Bargain Growth/Value 15 190 -22.07% 20.65% 0.65% 0.65% 6.12% 0.07 0.83 0.42% 0.34% 0.65% 0.01%
Fisher (Philip) Growth/Value 20 190 -27.96% 32.76% 0.69% 0.38% 10.06% 0.05 1.06 0.47% 0.07% 0.38% -0.16%
O'Neil's CAN SLIM Growth/Price MOM 6 190 -23.48% 69.59% 2.05% 1.90% 8.72% 0.21 1.77 1.82% 1.59% 1.90% 1.28%
O'Neil's CAN SLIM No Float Growth/Price MOM 16 190 -35.58% 23.44% 1.34% 1.32% 6.38% 0.18 0.87 1.11% 1.01% 1.32% 0.57%
O'Neil's CAN SLIM Revised Growth/Price MOM 8 190 -27.09% 52.24% 1.47% 1.32% 8.55% 0.15 1.45 1.24% 1.01% 1.32% 0.70%
Kirkpatrick Growth Growth/Price MOM 11 190 -23.59% 63.68% 1.52% 1.29% 9.63% 0.14 1.60 1.30% 0.98% 1.29% 0.75%
Driehaus Growth/Price MOM 15 190 -26.02% 50.86% 1.27% 0.98% 10.06% 0.11 1.38 1.04% 0.67% 0.98% 0.50%
Foolish Small Cap 8 Growth/Price MOM 16 190 -22.97% 38.37% 1.18% 0.88% 10.21% 0.10 1.37 0.95% 0.57% 0.88% 0.41%
Dual Cash Flow Growth 20 190 -23.67% 34.31% 1.20% 1.15% 7.07% 0.14 1.15 0.97% 0.84% 1.15% 0.59%
Inve$t Ware Quality Growth Growth 32 190 -22.46% 17.72% 0.55% 0.57% 5.77% 0.06 0.84 0.32% 0.26% 0.57% -0.13%
Return on Equity Growth 39 190 -22.59% 14.62% 1.04% 1.06% 5.92% 0.14 0.78 0.82% 0.75% 1.06% 0.40%
IBD Stable 70 price Growth 68 190 -22.02% 18.38% 0.87% 0.91% 5.46% 0.12 0.82 0.64% 0.60% 0.91% 0.24%
Est. Rev: Up 5 Earnings Estimates 42 190 -22.17% 30.41% 2.22% 2.09% 8.08% 0.25 1.03 1.99% 1.78% 2.09% 1.45%
Est. Rev. Top 30 Up Earnings Estimates 178 190 -27.17% 35.93% 2.12% 1.97% 8.44% 0.23 1.00 1.90% 1.66% 1.97% 1.35%
P/E Relative Earnings Estimates 32 190 -18.36% 18.44% 1.26% 1.32% 5.24% 0.20 0.92 1.04% 1.01% 1.32% 0.63%
Dreman With Est. Revisions Earnings Estimates 13 190 -26.26% 21.43% 1.25% 1.24% 6.26% 0.17 0.60 1.02% 0.93% 1.24% 0.62%
Est. Rev: Lowest 30 Down Earnings Estimates 218 190 -29.96% 42.98% 0.44% 0.07% 10.75% 0.02 1.13 0.22% -0.24% 0.07% -0.41%
Est. Rev: Down 5 Earnings Estimates 76 190 -30.59% 33.49% 0.28% 0.06% 9.02% 0.01 0.94 0.05% -0.25% 0.06% -0.58%
(rm-rf) 190 -17.15% 11.34% 0.44% 0.32% 4.80%
SMB 190 -11.60% 14.62% 0.36% 0.31% 3.24%
HML 190 -20.79% 19.72% 0.16% 0.06% 4.35%
MOM 190 -34.72% 18.39% 0.41% 0.23% 5.86%
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Appendix II. Capital Asset Pricing Model Regression Results  
  
Table 2. Capital Asset Pricing Model Regression Results
Portfolio name Strategy α (rm-rf) R2
Adjusted 
R2
F
Buffett: Hagstrom Growth/Value 0.70*** 0.95*** 0.80 0.80 744.06
(0.17) (0.03)
Buffettology: EPS Growth Growth/Value 0.41** 1.02*** 0.76 0.76 593.29
(0.20) (0.04)
Buffettology: Sustainable Growth Growth/Value 0.45** 1.05*** 0.73 0.73 515.21
(0.22) (0.05)
O'Neil's CAN SLIM Growth/Price MOM 1.81*** 0.57*** 0.09 0.08 17.95
(0.61) (0.13)
O'Neil's CAN SLIM Revised Growth/Price MOM 1.08** 0.89*** 0.25 0.25 63.30
(0.54) (0.11)
O'Neil's CAN SLIM No Float Growth/Price MOM 0.97*** 0.84*** 0.40 0.40 127.01
(0.36) (0.07)
Cash Rich Firms Value 0.42 1.08*** 0.67 0.67 379.94
(0.27) (0.06)
Dual Cash Flow Growth 0.70** 1.14*** 0.60 0.60 283.16
(0.33) (0.07)
Dividend (High Relative Yield) Growth/Value 0.33* 0.72*** 0.61 0.61 297.28
(0.20) (0.04)
Dogs of the Dow Value -0.19 0.86*** 0.54 0.53 217.03
(0.28) (0.06)
Dogs of the Dow LowPriced 5 Value -0.19 1.01*** 0.44 0.44 146.53
(0.40) (0.08)
Dreman Growth/Value 0.48 0.83*** 0.47 0.47 169.87
(0.31) (0.06)
Dreman With Est. Revisions Earnings Estimates 0.88** 0.83*** 0.41 0.40 129.55
(0.35) (0.07)
Driehaus Growth/Price MOM 0.68 1.33*** 0.40 0.40 127.72
(0.57) (0.12)
Dividend Screen DRP Growth/Value 0.28 0.75*** 0.50 0.49 184.33
(0.26) (0.06)
Dividend Screen Non-DRP Growth/Value 0.61*** .63*** 0.49 0.49 183.94
(0.22) (0.05)
Est. Rev: Lowest 30 Down Earnings Estimates -0.37 1.85*** 0.68 0.68 399.09
(0.44) (0.09)
Est. Rev: Down 5 Earnings Estimates -0.41 1.58*** 0.71 0.70 451.77
(0.36) (0.07)
Est. Rev. Top 30 Up Earnings Estimates 1.52*** 1.36*** 0.60 0.60 285.24
(0.39) (0.08)
Est. Rev: Up 5 Earnings Estimates 1.65*** 1.29*** 0.58 0.58 264.39
(0.38) (0.08)
Fisher (Philip) Growth/Value 0.03 1.51*** 0.52 0.52 204.52
(0.51) (0.11)
Foolish Small Cap 8 Growth/Price MOM 0.54 1.45*** 0.47 0.46 164.52
(0.54) (0.11)
Foolish Small Cap 8 Revised Growth/Value 0.97* 1.19*** 0.33 0.33 93.46
(0.59) (0.12)
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 Table 2. (continued) 
Portfolio name Strategy α (rm-rf) R2
Adjusted 
R2
F
Price-to-Free Cash Flow Value 1.17*** 1.22*** 0.51 0.51 195.30
(0.42) (0.09)
Fundamental Rule of Thumb Value 0.71* 1.17*** 0.51 0.51 194.84
(0.40) (0.08)
Graham Defensive Investor Non-Utility Value 1.01*** 0.92*** 0.49 0.49 181.35
(0.33) (0.07)
Graham Defensive Investor Utility Value 0.36 0.41*** 0.22 0.22 53.81
(0.27) (0.06)
Graham Enterprising Investor Value 1.21** 0.69*** 0.17 0.17 38.38
(0.54) (0.11)
Graham Enterprising Investor Revised Value 1.36*** 0.92*** 0.30 0.30 82.01
(0.49) (0.10)
IBD Stable 70 price Growth 0.45** 0.95*** 0.70 0.70 431.77
(0.22) (0.05)
Insider Net Purchases Specialty -0.44 1.19*** 0.50 0.50 186.32
(0.42) (0.09)
Inve$t Ware Quality Growth Growth 0.11 0.99*** 0.68 0.68 404.12
(0.24) (0.05)
Kirkpatrick Bargain Growth/Value 0.35 0.68*** 0.28 0.28 74.23
(0.38) (0.08)
Kirkpatrick Growth Growth/Price MOM 1.09* 0.97*** 0.24 0.23 57.86
(0.62) (0.13)
Kirkpatrick Value Growth/Value 0.97 0.55*** 0.07 0.07 14.34
(0.69) (0.14)
Lakonishok Value/Price MOM 0.71*** 0.88*** 0.58 0.57 255.53
(0.26) (0.05)
Lynch Growth/Value 0.61** 0.83*** 0.50 0.50 190.52
(0.29) (0.06)
Magic Formula Value 0.45 1.18*** 0.56 0.55 234.77
(0.37) (0.08)
MAGNET Complex Growth/Value/Price MOM 1.03 0.97*** 0.14 0.14 30.55
(0.85) (0.18)
MAGNET Simple Growth/Value/Price MOM 1.52 1.28*** 0.20 0.19 45.78
0.91* (0.19)
Muhlenkam Growth/Value/Price MOM -0.08 0.91*** 0.46 0.45 158.15
(0.35) (0.07)
Murphy Technology Growth/Value -0.19 1.55*** 0.34 0.33 95.57
(0.76) (0.16)
Neff Growth/Value 1.15*** 1.16*** 0.55 0.55 228.70
(0.37) (0.08)
O'Shaughnessy All Cap Value/Price MOM 0.63* 0.92*** 0.49 0.49 180.60
(0.33) (0.07)
O'Shaughnessy Growth Market Leaders Value/Price MOM 0.17 0.91*** 0.60 0.60 285.52
(0.26) (0.05)
O'Shaughnessy Growth Value/Price MOM 0.89*** 1.14*** 0.61 0.61 296.85
(0.32) (0.07)
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Table 2. (continued) 
Portfolio name Strategy α (rm-rf) R2
Adjusted 
R2
F
O'Shaughnessy Small Cap Growth and Value Value/Price MOM 1.09*** 1.06*** 0.54 0.53 217.53
(0.35) (0.07)
O'Shaughnessy Tiny Titans Value/Price MOM 1.56*** 1.26*** 0.46 0.46 161.03
(0.48) (0.10)
O'Shaughnessy Value Value 0.03 1.01*** 0.61 0.61 295.21
(0.28) (0.06)
Oberweis Octagon Growth/Value/Price MOM 0.80 1.18*** 0.41 0.41 133.08
(0.49) (0.10)
P/E Relative Earnings Estimates 0.89*** 0.85*** 0.60 0.60 283.41
(0.24) (0.05)
Value on the Move PEG With Est. Growth Growth/Value/Price MOM 1.09*** 1.01*** 0.62 0.62 311.93
(0.27) (0.06)
Value on the Move PEG With Hist. Growth Growth/Value/Price MOM 0.72*** 0.79*** 0.63 0.63 320.82
(0.21) (0.04)
Piotroski High F-Score Value 2.14*** 0.99*** 0.25 0.24 61.26
(0.61) (0.13)
Piotroski: 9 Value 2.97*** 0.51*** 0.05 0.04 9.31
(0.80) (0.17)
Price-to-Sales Growth/Value 0.78*** 1.04*** 0.67 0.66 374.75
(0.26) (0.05)
Return on Equity Growth 0.58*** 1.06*** 0.73 0.73 517.21
(0.22) (0.05)
Rule #1 Investing Growth/Value 0.57 1.29*** 0.57 0.57 250.84
(0.39) (0.08)
Schloss Value 0.71 0.54*** 0.25 0.25 62.86
(0.88) (0.11)
Shadow Stock Screen Growth/Value 0.90** 0.70*** 0.29 0.29 76.60
(0.38) (0.08)
T. Rowe Growth/Value 0.53 0.91*** 0.32 0.31 86.59
(0.47) (0.10)
Templeton Growth/Value 0.44* 0.94*** 0.63 0.63 316.88
(0.25) (0.05)
Wanger Revised Growth/Value 0.30 1.14*** 0.68 0.68 400.25
(0.27) (0.06)
Weiss Blue Chip Div. Yield Value 0.45* 0.90*** 0.59 0.59 271.80
(0.26) (0.05)
Stock Market Winners Growth/Value/Price MOM 1.44*** 0.49*** 0.12 0.12 25.63
(0.47) (0.10)
Zweig Growth/Value 1.13** 1.13*** 0.43 0.43 143.43
(0.45) (0.09)
Note: Standard errors are shown in parentheses; * indicates significance at the 90% level, ** at 95%, and *** at 99%
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Appendix III. Fama-French Three-Factor Model Regression Results  
 
Table 3. Fama-French Three Factor Model Regression Results 
Portfolio name Strategy α (rm-rf) SMB HML R2
Adjusted 
R2
F
Buffett: Hagstrom Growth/Value 0.66*** 0.93*** 0.09* 0.08** 0.80 0.80 255.82
(0.17) (0.04) (0.06) (0.04)
Buffettology: EPS Growth Growth/Value 0.30* 0.94*** 0.36*** 0.15*** 0.80 0.80 251.86
(0.18) (0.04) (0.06) (0.04)
Buffettology: Sustainable Growth Growth/Value 0.32 0.96*** 0.38*** 0.21*** 0.78 0.78 226.17
(0.20) (0.04) (0.07) (0.05)
O'Neil's CAN SLIM Growth/Price MOM 1.73*** 0.45*** 0.44** -0.24* 0.13 0.12 9.46
(0.60) (0.13) (0.20) (0.14)
O'Neil's CAN SLIM Revised Growth/Price MOM 1.00** 0.77*** 0.68*** -0.71*** 0.47 0.46 55.68
(0.46) (0.10) (0.15) (0.11)
O'Neil's CAN SLIM No Float Growth/Price MOM 0.93*** 0.79*** 0.31*** -0.33*** 0.49 0.48 58.73
(0.34) (0.07) (0.11) (0.08)
Cash Rich Firms Value 0.25 0.95*** 0.58*** .075 0.74 0.74 180.86
(0.24) (0.05) (0.08) (0.05)
Dual Cash Flow Growth 0.47* 0.97*** 0.71*** 0.28*** 0.71 0.70 149.10
(0.28) (0.06) (0.09) (0.07)
Dividend (High Relative Yield) Growth/Value 0.24 0.68*** 0.14*** 0.38*** 0.75 0.74 183.53
(0.16) (0.04) (0.05) (0.04)
Dogs of the Dow Value -0.18 0.91*** -0.31*** 0.50*** 0.74 0.73 173.15
(0.21) (0.05) (0.07) (0.05)
Dogs of the Dow LowPriced 5 Value -0.22 1.04*** -0.28*** 0.70*** 0.64 0.63 110.41
(0.32) (0.07) (0.11) (0.08)
Dreman Growth/Value 0.36 0.77*** 0.18** 0.51*** 0.62 0.61 99.75
(0.26) (0.06) (0.09) (0.06)
Dreman With Est. Revisions Earnings Estimates 0.86** 0.83*** -.030 0.23*** 0.43 0.43 47.69
(0.35) (0.08) (0.11) (0.08)
Driehaus Growth/Price MOM 0.45 1.11*** 1.06*** -0.31*** 0.54 0.53 73.13
(0.50) (0.11) (0.17) (0.12)
Dividend Screen DRP Growth/Value 0.16 0.70*** 0.11* 0.63*** 0.77 0.77 210.77
(0.18) (0.04) (0.06) (0.04)
Dividend Screen Non-DRP Growth/Value 0.49*** 0.56*** 0.25*** 0.42*** 0.68 0.67 129.32
(0.18) (0.04) (0.06) (0.04)
Est. Rev: Lowest 30 Down Earnings Estimates -0.72** 1.60*** 1.00*** 0.71*** 0.81 0.81 265.00
(0.35) (0.08) (0.11) (0.08)
Est. Rev: Down 5 Earnings Estimates -0.72*** 1.37*** 0.81*** 0.67*** 0.86 0.85 366.45
(0.25) (0.06) (0.08) (0.06)
Est. Rev. Top 30 Up Earnings Estimates 1.37*** 1.22*** 0.71*** -0.29*** 0.71 0.70 148.73
(0.34) (0.07) (0.11) (0.08)
Est. Rev: Up 5 Earnings Estimates 1.54*** 1.16*** 0.62*** -0.37*** 0.69 0.69 141.17
(0.33) (0.07) (0.11) (0.08)
Fisher (Philip) Growth/Value -.23 1.32*** 0.76*** 0.43*** 0.59 0.59 90.58
(0.47) (0.10) (0.16) (0.11)
Foolish Small Cap 8 Growth/Price MOM 0.41 1.30*** 0.80*** -0.57*** 0.60 0.60 93.83
(0.48) (0.10) (0.16) (0.11)
Foolish Small Cap 8 Revised Growth/Value 0.82 1.05*** 0.64*** -.099 0.38 0.37 37.38
(0.58) (0.13) (0.19) (0.13)
Price-to-Free Cash Flow Value 0.81*** 0.99*** 0.85*** 0.93*** 0.80 0.79 242.67
(0.27) (0.06) (0.09) (0.06)
Fundamental Rule of Thumb Value 0.40 0.93*** 0.97*** 0.37*** 0.67 0.66 124.32
(0.33) (0.07) (0.11) (0.08)
Graham Defensive Investor Non-Utility Value 0.78*** 0.76*** 0.63*** 0.49*** 0.66 0.66 121.51
(0.27) (0.06) (0.09) (0.06)
Graham Defensive Investor Utility Value 0.36 0.43*** -0.15* 0.29*** 0.34 0.33 31.37
(0.25) (0.06) (0.08) (0.06)
Graham Enterprising Investor Value 1.08** 0.59*** 0.36** 0.38*** 0.22 0.21 17.52
(0.52) (0.12) (0.17) (0.12)
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Table 3. (continued)
Portfolio name Strategy α (rm-rf) SMB HML R2
Adjusted 
R2
F
(0.43) (0.10) (0.14) (0.10)
IBD Stable 70 price Growth 0.36* 0.89*** 0.22*** 0.22*** 0.74 0.73 171.97
(0.21) (0.05) (0.07) (0.05)
Insider Net Purchases Specialty -0.78** 0.92*** 1.15*** 0.30*** 0.68 0.68 134.79
(0.34) (0.07) (0.11) (0.08)
Inve$t Ware Quality Growth Growth 0.04 0.94*** 0.20*** 0.10* 0.70 0.69 142.52
(0.23) (0.05) (0.08) (0.05)
Kirkpatrick Bargain Growth/Value 0.28 0.63*** 0.21* .139 0.30 0.29 26.58
(0.38) (0.08) (0.12) (0.09)
Kirkpatrick Growth Growth/Price MOM 1.01* 0.85*** 0.68*** -0.70*** 0.41 0.40 42.38
(0.55) (0.12) (0.18) (0.13)
Kirkpatrick Value Growth/Value 0.83 0.45*** 0.38* 0.30* 0.10 0.08 6.64
(0.69) (0.15) (0.23) (0.16)
Lakonishok Value/Price MOM 0.61** 0.80*** 0.33*** 0.12** 0.61 0.61 98.06
(0.25) (0.06) (0.08) (0.06)
Lynch Growth/Value 0.44* 0.71*** 0.50*** 0.28*** 0.60 0.60 94.27
(0.26) (0.06) (0.09) (0.06)
Magic Formula Value 0.15 0.97*** 0.83*** 0.61*** 0.75 0.74 182.38
(0.28) (0.06) (0.09) (0.07)
MAGNET Complex Growth/Value/Price MOM 1.00 0.90*** .433 -0.60*** 0.20 0.19 15.77
(0.82) (0.18) (0.27) (0.19)
MAGNET Simple Growth/Value/Price MOM 1.31 1.10*** 0.74*** .144 0.22 0.21 17.72
(0.90) (0.20) (0.30) (0.21)
Muhlenkam Growth/Value/Price MOM -0.30 0.75*** 0.60*** 0.45*** 0.60 0.59 93.32
(0.30) (0.07) (0.10) (0.07)
Murphy Technology Growth/Value -0.39 1.38*** 0.78*** -.042 0.37 0.36 36.68
(0.75) (0.17) (0.25) (0.17)
Neff Growth/Value 0.84*** 0.96*** 0.78*** 0.76*** 0.79 0.79 235.71
(0.25) (0.06) (0.08) (0.06)
O'Shaughnessy All Cap Value/Price MOM 0.48 0.83*** 0.34*** 0.39*** 0.57 0.57 82.89
(0.31) (0.07) (0.10) (0.07)
O'Shaughnessy Growth Market Leaders Value/Price MOM 0.17 0.90*** .057 -0.12** 0.61 0.61 98.72
(0.26) (0.06) (0.09) (0.06)
O'Shaughnessy Growth Value/Price MOM 0.74*** 1.00*** 0.60*** -.031 0.68 0.68 133.29
(0.29) (0.06) (0.10) (0.07)
O'Shaughnessy Small Cap Growth and Value Value/Price MOM 0.93*** 0.92*** 0.63*** -.001 0.61 0.61 98.30
(0.32) (0.07) (0.11) (0.07)
O'Shaughnessy Tiny Titans Value/Price MOM 1.29*** 1.02*** 1.06*** -.026 0.60 0.59 91.45
(0.42) (0.09) (0.14) (0.10)
O'Shaughnessy Value Value -0.02 1.02*** -0.15** 0.65*** 0.84 0.83 314.55
(0.19) (0.04) (0.06) (0.04)
Oberweis Octagon Growth/Value/Price MOM 0.66 1.05*** 0.64*** -0.19* 0.48 0.47 56.95
(0.47) (0.10) (0.16) (0.11)
P/E Relative Earnings Estimates 0.83*** 0.82*** .083 0.29*** 0.66 0.65 118.83
(0.23) (0.05) (0.07) (0.05)
Value on the Move PEG With Est. Growth Growth/Value/Price MOM 0.92*** 0.87*** 0.61*** .038 0.72 0.71 156.17
(0.24) (0.05) (0.08) (0.06)
Value on the Move PEG With Hist. Growth Growth/Value/Price MOM 0.61*** 0.69*** 0.47*** -.040 0.73 0.72 164.18
(0.19) (0.04) (0.06) (0.04)
Piotroski High F-Score Value 1.80*** 0.76*** 0.89*** 0.75*** 0.41 0.40 42.91
(0.54) (0.12) (0.18) (0.13)
Piotroski: 9 Value 2.76*** 0.34* 0.74*** .083 0.09 0.07 5.91
(0.79) (0.17) (0.26) (0.18)
Price-to-Sales Growth/Value 0.54*** 0.85*** 0.76*** 0.28*** 0.83 0.82 294.93
(0.19) (0.04) (0.06) (0.04)
Return on Equity Growth 0.43** 0.93*** 0.56*** .02 0.82 0.81 275.19
(0.19) (0.04) (0.06) (0.04)
Rule #1 Investing Growth/Value 0.33 1.11*** 0.67*** 0.48*** 0.68 0.67 130.81
(0.34) (0.08) (0.11) (0.08)
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Table 3. (continued)
Portfolio name Strategy α (rm-rf) SMB HML R2
Adjusted 
R2
F
(0.52) (0.11) (0.17) (0.12)
Shadow Stock Screen Growth/Value 0.74** 0.60** 0.36** 0.44*** 0.39 0.39 40.45
(0.36) (0.08) (0.12) (0.08)
T. Rowe Growth/Value 0.34 0.77*** 0.53*** 0.36*** 0.39 0.38 38.81
(0.45) (0.10) (0.15) (0.10)
Templeton Growth/Value 0.32 0.86*** 0.30*** 0.27*** 0.68 0.68 133.74
(0.24) (0.05) (0.08) (0.06)
Wanger Revised Growth/Value 0.11 0.99*** 0.61*** 0.22*** 0.77 0.76 204.57
(0.24) (0.05) (0.08) (0.05)
Weiss Blue Chip Div. Yield Value 0.33 0.83*** 0.26*** 0.40*** 0.69 0.69 138.01
(0.23) (0.05) (0.08) (0.05)
Stock Market Winners Growth/Value/Price MOM 1.32*** 0.39*** 0.46*** 0.00*** 0.16 0.15 11.98
(0.46) (0.10) (0.15) (0.11)
Zweig Growth/Value 1.00** 1.04*** 0.37** 0.23** 0.46 0.45 52.89
(0.45) (0.10) (0.15) (0.10)
Note: Standard errors are shown in parentheses; * indicates significance at the 90% level, ** at 95%, and *** at 99%
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Appendix IV. Carhart Four-Factor Model Regression Results  
 
Table 4. Carhart's Four Factor Model Regression Results 
Portfolio name Strategy α (rm-rf) SMB HML MOM R2
Adjusted 
R2
F
Buffett: Hagstrom Growth/Value 0.68*** 0.92*** 0.09* 0.05 -0.03 0.81 0.80 191.44
(0.17) (0.04) (0.06) (0.06) (0.04)
Buffettology: EPS Growth Growth/Value 0.32* 0.93*** 0.35*** 0.12** -0.03 0.80 0.80 188.31
(0.19)  (0.04)  (0.06)  (0.06)  (0.05)
Buffettology: Sustainable Growth Growth/Value 0.41** 0.92*** 0.37*** 0.09 -.13** 0.79 0.79 174.99
(0.20) (0.05) (0.07) (0.07) (0.05)
O'Neil's CAN SLIM Growth/Price MOM 1.51*** 0.53*** 0.48*** 0.04 0.29* 0.15 0.13 7.98
(0.61) (0.14) (0.20) (0.21) (0.16)
O'Neil's CAN SLIM Revised Growth/Price MOM 0.72 0.88*** 0.73*** -0.35** 0.37*** 0.50 0.49 46.10
(0.46) (0.11) (0.15) (0.16) (0.12)
O'Neil's CAN SLIM No Float Growth/Price MOM 0.64** 0.91*** 0.37*** 0.06 0.40*** 0.54 0.53 54.18
(0.33) (0.08) (0.11) (0.11) (0.09)
Cash Rich Firms Value 0.29 0.93*** 0.57*** 0.03 -0.05 0.75 0.74 135.46
(0.24) (0.06) (0.08) (0.08) (0.06)
Dual Cash Flow Growth 0.43 0.99*** 0.72*** 0.34*** 0.06 0.71 0.70 111.73
(0.29) (0.07) (0.09) (0.10) (0.08)
Dividend (High Relative Yield) Growth/Value 0.13 0.72*** 0.16*** 0.52*** 0.15*** 0.76 0.76 148.44
(0.16) (0.04) (0.05) (0.06) (0.04)
Dogs of the Dow Value -0.19 0.92*** -0.31*** 0.52*** 0.02 0.74 0.73 129.25
(0.22) (0.05) (0.07) (0.07) (0.06)
Dogs of the Dow LowPriced 5 Value -0.23 1.05*** -0.28*** 0.71*** 0.02 0.64 0.63 82.38
(0.33) (0.08) (0.11) (0.11) (0.09)
Dreman Growth/Value 0.18 0.84*** 0.22*** 0.74*** 0.25*** 0.64 0.63 82.69
(0.26) (0.06) (0.09) (0.09) (0.07)
Dreman With Est. Revisions Earnings Estimates 0.59* 0.94*** 0.02 0.58*** 0.36*** 0.48 0.47 42.53
(0.34) (0.08) (0.11) (0.12) (0.09)
Driehaus Growth/Price MOM 0.53 1.07*** 1.05*** -0.42*** -0.11 0.54 0.53 54.94
(0.51) (0.12) (0.17) (0.18) (0.14)
Dividend Screen DRP Growth/Value 0.09 0.72*** 0.12* 0.71*** 0.09* 0.78 0.77 160.97
(0.18) (0.04) (0.06) (0.06) (0.05)
Dividend Screen Non-DRP Growth/Value 0.37** 0.61*** 0.27*** 0.57*** 0.15*** 0.69 0.69 104.45
(0.18) (0.04) (0.06) (0.06) (0.05)
Est. Rev: Lowest 30 Down Earnings Estimates -0.31 1.43*** 0.90*** 0.18* -0.55*** 0.85 0.84 253.06
(0.32) (0.07) (0.10) (0.11) (0.08)
Est. Rev: Down 5 Earnings Estimates -0.48** 1.27*** 0.77*** 0.36*** -0.32*** 0.87 0.87 315.67
(0.24) (0.06) (0.08) (0.08) (0.06)
Est. Rev. Top 30 Up Earnings Estimates 1.32*** 1.24*** 0.72*** -0.22* 0.08 0.71 0.70 111.54
(0.34) (0.08) (0.11) (0.12) (0.09)
Est. Rev: Up 5 Earnings Estimates 1.49*** 1.18*** 0.63*** -0.30*** 0.07 0.70 0.70 105.76
(0.34) (0.08) (0.11) (0.12) (0.09)
Fisher (Philip) Growth/Value -0.06 1.25*** 0.73*** 0.20 -0.23* 0.60 0.59 69.64
(0.48) (0.11) (0.16) (0.16) (0.13)
Foolish Small Cap 8 Growth/Price MOM 0.03 1.45*** 0.87*** -0.07 0.51*** 0.64 0.63 80.93
(0.46) (0.11) (0.15) (0.16) (0.12)
Foolish Small Cap 8 Revised Growth/Value 0.72 1.09*** 0.66*** 0.03 0.13 0.38 0.37 28.17
(0.59) (0.14) (0.19) (0.20) (0.16)
Price-to-Free Cash Flow Value 0.78*** 1.01*** 0.86*** 0.98*** 0.05 0.80 0.79 181.65
(0.28) (0.06) (0.09) (0.10) (0.07)
Fundamental Rule of Thumb Value 0.49 0.90*** 0.96*** 0.26** -0.11 0.67 0.66 93.87
(0.34) (0.08) (0.11) (0.12) (0.09)
Graham Defensive Investor Non-Utility Value 0.67*** 0.80*** 0.65*** 0.62*** 0.14** 0.67 0.66 93.37
(0.27) (0.06) (0.09) (0.09) (0.07)
Graham Defensive Investor Utility Value 0.13 0.53*** -0.11 0.59*** 0.31*** 0.41 0.40 32.46
(0.24) (0.06) (0.08) (0.08) (0.06)
Graham Enterprising Investor Value 0.94* 0.64*** 0.39** 0.53*** 0.16 0.23 0.21 13.49
(0.54) (0.12) (0.17) (0.18) (0.14)
Graham Enterprising Investor Revised Value 1.06*** 0.76*** 0.68*** 0.70*** 0.05 0.46 0.45 39.90
(0.44) (0.10) (0.14) (0.15) (0.12)
IBD Stable 70 price Growth 0.25 0.94*** 0.24*** 0.36*** 0.14*** 0.74 0.74 134.87
(0.21) (0.05) (0.07) (0.07) (0.05)
Insider Net Purchases Specialty -0.71** 0.89*** 1.13*** 0.21* -0.09 0.69 0.68 101.39
(0.34) (0.08) (0.11) (0.12) (0.09)
Inve$t Ware Quality Growth Growth 0.04 0.95*** 0.20*** 0.11 0.01 0.70 0.69 106.34
(0.24) (0.06) (0.08) (0.08) (0.06)
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Table 4. (continued)
Portfolio name Strategy α (rm-rf) SMB HML MOM R2
Adjusted 
R2
F
Kirkpatrick Bargain Growth/Value -0.06 0.77*** 0.27** 0.58*** 0.46*** 0.38 0.36 27.83
(0.36) (0.08) (0.12) (0.12) (0.10)
Kirkpatrick Growth Growth/Price MOM 0.88 0.90*** 0.70*** -0.53*** 0.18 0.41 0.40 32.24
(0.56) (0.13) (0.18) (0.19) (0.15)
Kirkpatrick Value Growth/Value 0.49 0.59*** 0.45** 0.74*** 0.45*** 0.13 0.11 6.65
(0.70) (0.16) (0.23) (0.24) (0.18)
Lakonishok Value/Price MOM 0.47* 0.85*** 0.36*** 0.30*** 0.19*** 0.63 0.62 78.08
(0.25) (0.06) (0.08) (0.09) (0.07)
Lynch Growth/Value 0.39 0.73*** 0.51*** 0.36*** 0.07 0.61 0.60 71.03
(0.27) (0.06) (0.09) (0.09) (0.07)
Magic Formula Value 0.22 0.94*** 0.81*** 0.51*** -0.10 0.75 0.74 137.70
(0.29) (0.07) (0.09) (0.10) (0.08)
MAGNET Complex Growth/Value/Price MOM 0.84 0.97*** 0.46* -0.39 0.22 0.21 0.19 12.06
(0.84) (0.19) (0.27) (0.29) (0.22)
MAGNET Simple Growth/Value/Price MOM 1.02 1.22*** 0.80*** 0.51* 0.38 0.23 0.22 14.01
(0.91) (0.21) (0.30) (0.31) (0.24)
Muhlenkam Growth/Value/Price MOM -0.43 0.81*** 0.63*** 0.63*** 0.18** 0.61 0.60 72.79
(0.30) (0.07) (0.10) (0.10) (0.08)
Murphy Technology Growth/Value 0.07 1.19*** 0.68*** -0.64*** -0.61*** 0.40 0.39 31.23
(0.75) (0.17) (0.24) (0.26) (0.20)
Neff Growth/Value 0.80*** 0.97*** 0.79*** 0.80*** 0.05 0.79 0.79 176.39
(0.26) (0.06) (0.08) (0.09) (0.07)
O'Shaughnessy All Cap Value/Price MOM 0.13 0.98*** 0.41*** 0.85*** 0.47*** 0.65 0.64 85.34
(0.28) (0.07) (0.09) (0.10) (0.07)
O'Shaughnessy Growth Market Leaders Value/Price MOM -0.23 1.07*** 0.13* 0.39*** 0.53*** 0.74 0.73 130.28
(0.22) (0.05) (0.07) (0.07) (0.06)
O'Shaughnessy Growth Value/Price MOM 0.28 1.19*** 0.68*** 0.56*** 0.61*** 0.79 0.78 172.44
(0.24) (0.06) (0.08) (0.08) (0.06)
O'Shaughnessy Small Cap Growth and Value Value/Price MOM 0.43 1.12*** 0.72*** 0.64*** 0.66*** 0.74 0.73 128.45
(0.27) (0.06) (0.09) (0.09) (0.07)
O'Shaughnessy Tiny Titans Value/Price MOM 1.03*** 1.12*** 1.11*** 0.30** 0.34*** 0.62 0.61 74.02
(0.42) (0.10) (0.14) (0.14) (0.11)
O'Shaughnessy Value Value -0.07 1.04*** -0.14** 0.72*** 0.08 0.84 0.83 238.21
(0.19) (0.04) (0.06) (0.06) (0.05)
Oberweis Octagon Growth/Value/Price MOM 0.23 1.22*** 0.72*** 0.37** 0.57*** 0.54 0.53 53.32
(0.45) (0.11) (0.15) (0.16) (0.12)
P/E Relative Earnings Estimates 0.63*** 0.90*** 0.12* 0.55*** 0.27*** 0.69 0.69 105.00
(0.22) (0.05) (0.07) (0.07) (0.06)
Value on the Move PEG With Est. Growth Growth/Value/Price MOM 0.66*** 0.98*** 0.66*** 0.39*** 0.36*** 0.76 0.76 148.68
(0.22) (0.05) (0.07) (0.08) (0.06)
Value on the Move PEG With Hist. Growth Growth/Value/Price MOM 0.34** 0.80*** 0.52*** 0.31*** 0.36*** 0.80 0.80 186.37
(0.16) (0.04) (0.05) (0.06) (0.04)
Piotroski High F-Score Value 1.92*** 0.70*** 0.87* 0.59*** -0.17 0.41 0.40 32.56
(0.55) (0.13) (0.18) (0.19) (0.15)
Piotroski: 9 Value 2.66*** 0.38** 0.76*** 0.22 0.14 0.09 0.07 4.53
(0.81) (0.19) (0.26) (0.28) (0.21)
Price-to-Sales Growth/Value 0.41** 0.91*** 0.79*** 0.45*** 0.17*** 0.84 0.83 238.48
(0.19) (0.04) (0.06) (0.06) (0.05)
Return on Equity Growth 0.33* 0.97*** 0.58*** 0.15** 0.13*** 0.82 0.82 214.14
(0.19) (0.04) (0.06) (0.06) (0.05)
Rule #1 Investing Growth/Value 0.51 1.04*** 0.64*** 0.25** -0.25*** 0.69 0.68 103.32
(0.34) (0.08) (0.11) (0.12) (0.09)
Schloss Value 0.71 0.67*** 0.51*** 0.11 -0.26* 0.32 0.31 22.03
(0.53) (0.12) (0.17) (0.18) (0.14)
Shadow Stock Screen Growth/Value 0.55 0.68*** 0.40*** 0.68*** 0.25*** 0.42 0.40 33.10
(0.36) (0.08) (0.12) (0.12) (0.09)
T. Rowe Growth/Value 0.37 0.76*** 0.53*** 0.31** -0.05 0.39 0.37 29.01
(0.46) (0.11) (0.15) (0.16) (0.12)
Templeton Growth/Value 0.43* 0.82*** 0.28*** 0.12 -0.15** 0.69 0.69 104.17
(0.24) (0.06) (0.08) (0.08) (0.06)
Wanger Revised Growth/Value 0.10 0.99*** 0.62*** 0.22*** 0.00 0.77 0.76 152.61
(0.24) (0.06) (0.08) (0.08) (0.06)
Weiss Blue Chip Div. Yield Value 0.38* 0.81*** 0.25*** 0.33*** -0.07 0.69 0.69 103.98
(0.24) (0.05) (0.08) (0.08) (0.06)
Stock Market Winners Growth/Value/Price MOM 1.08** 0.49*** 0.50*** 0.32** 0.32*** 0.19 0.18 11.05
(0.46) (0.11) (0.15) (0.16) (0.12)
Zweig Growth/Value 0.60 1.21*** 0.45*** 0.76*** 0.54*** 0.52 0.51 49.96
(0.43) (0.10) (0.14) (0.15) (0.11)
Note: Standard errors are shown in parentheses; * indicates significance at the 90% level, ** at 95%, and *** at 99%. Portfolios with positive momentum factor are highlighted in 
green and portfolios with negative momentum factor are highlighted in red. 
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Appendix V. Carhart Four-Factor Model Adjusted for Transaction Costs  
 
Table 5. Carhart's Four Factor Model Regression Results - Adjusted for Transaction Costs Using a Hypothetical $50,000 Portfolio 
Portfolio name Strategy Number 
of Stocks 
 
Transaction 
Costs  
α (rm-rf) SMB HML MOM R2
Adjusted 
R2
F
Buffett: Hagstrom Growth/Value 30 420.00$      -0.16 0.92*** 0.09* 0.05 -0.03 0.81 0.80 191.44
(0.17) (0.04) (0.06) (0.06) (0.04)
Buffettology: EPS Growth Growth/Value 47 658.00$      -1.00*** 0.93*** 0.35*** 0.12** -0.03 0.80 0.80 188.31
(0.19) (0.04) (0.06) (0.06) (0.05)
Buffettology: Sustainable Growth Growth/Value 33 462.00$      -0.51** 0.92*** 0.37*** 0.09 -0.13** 0.79 0.79 174.99
(0.20) (0.05) (0.07) (0.07) (0.05)
O'Neil's CAN SLIM Growth/Price MOM 6 84.00$        1.35** 0.53*** 0.48** 0.04 0.29* 0.15 0.13 7.98
(0.61) (0.14) (0.20) (0.21) (0.16)
O'Neil's CAN SLIM No Float Growth/Price MOM 16 224.00$      0.19 0.91*** 0.37*** 0.06 0.40*** 0.54 0.53 54.18
(0.33) (0.08) (0.11) (0.11) (0.09)
Dreman With Est. Revisions Earnings Estimates 21 294.00$      0.01 0.94*** 0.02 0.58*** 0.36*** 0.48 0.47 42.53
(0.34) (0.08) (0.11) (0.12) (0.09)
Dividend Screen Non-DRP Growth/Value 30 420.00$      -0.47** 0.61*** 0.28*** 0.57*** 0.15*** 0.69 0.69 104.45
(0.18) (0.04) (0.06) (0.06) (0.05)
Est. Rev: Down 5 Earnings Estimates 76 1,064.00$   -2.61*** 1.27*** 0.77*** 0.36*** -0.32*** 0.87 0.87 315.67
(0.24) (0.06) (0.08) (0.08) (0.06)
Est. Rev. Top 30 Up Earnings Estimates 178 2,492.00$   -3.66*** 1.24*** 0.72*** -0.22* 0.08 0.71 0.70 111.54
(0.34) (0.08) (0.11) (0.12) (0.09)
Est. Rev: Up 5 Earnings Estimates 42 588.00$      0.31 1.18*** 0.63*** -0.30*** 0.07 0.70 0.69 105.76
(0.34) (0.08) (0.11) (0.12) (0.09)
Price-to-Free Cash Flow Value 30 420.00$      -0.06 1.01*** 0.86*** 0.98*** 0.05 0.80 0.79 181.65
(0.28) (0.06) (0.09) (0.10) (0.07)
Graham Defensive Investor Non-Utility Value 21 294.00$      0.09 0.80*** 0.65*** 0.62*** 0.14** 0.67 0.66 93.37
(0.27) (0.06) (0.09) (0.09) (0.07)
Graham Enterprising Investor Value 4 56.00$        0.82 0.64*** 0.39** 0.53*** 0.16 0.23 0.21 13.49
(0.54) (0.12) (0.17) (0.18) (0.14)
Graham Enterprising Investor Revised Value 9 126.00$      0.81* 0.76*** 0.68*** 0.70*** 0.05 0.46 0.45 39.90
(0.44) (0.10) (0.14) (0.15) (0.12)
Insider Net Purchases Specialty 28 392.00$      -1.50*** 0.89*** 1.13*** 0.21* -0.09 0.69 0.68 101.39
(0.34) (0.08) (0.11) (0.12) (0.09)
Lakonishok Value/Price MOM 31 434.00$      -0.40 0.85*** 0.36*** 0.30*** 0.19*** 0.63 0.62 78.08
(0.25) (0.06) (0.08) (0.09) (0.07)
Neff Growth/Value 22 308.00$      0.19 0.97*** 0.79*** 0.80*** 0.05 0.79 0.79 176.39
(0.26) (0.06) (0.08) (0.09) (0.07)
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Table 5. (continued)
Portfolio name Strategy Number 
of Stocks 
 
Transaction 
Costs  
α (rm-rf) SMB HML MOM R2
Adjusted 
R2
F
O'Shaughnessy Tiny Titans Value/Price MOM 25 350.00$      0.33 1.12*** 1.11*** 0.30** 0.34*** 0.62 0.61 74.02
(0.42) (0.10) (0.14) (0.14) (0.11)
P/E Relative Earnings Estimates 32 448.00$      -0.27 0.90*** 0.12* 0.55*** 0.27*** 0.69 0.69 105.00
(0.22) (0.05) (0.07) (0.07) (0.06)
Value on the Move PEG With Est. Growth Growth/Value/Price MOM 40 560.00$      -0.46** 0.98*** 0.66*** 0.39*** 0.36*** 0.76 0.76 148.68
(0.22) (0.05) (0.07) (0.08) (0.06)
Value on the Move PEG With Hist. Growth Growth/Value/Price MOM 80 1,120.00$   -1.91*** 0.80*** 0.52*** 0.31*** 0.36*** 0.80 0.80 186.37
(0.16) (0.04) (0.05) (0.06) (0.04)
Piotroski High F-Score Value 21 294.00$      1.34** 0.70*** 0.87*** 0.59*** -0.17 0.41 0.40 32.56
(0.55) (0.13) (0.18) (0.19) (0.15)
Piotroski: 9 Value 9 126.00$      2.40*** 0.38** 0.76*** 0.22 0.14 0.09 0.07 4.53
(0.81) (0.19) (0.26) (0.28) (0.21)
Price-to-Sales Growth/Value 55 770.00$      -1.13*** 0.91*** 0.79*** 0.45*** 0.17*** 0.84 0.83 238.48
(0.19) (0.04) (0.06) (0.06) (0.05)
Return on Equity Growth 32 448.00$      -0.56*** 0.97*** 0.58*** 0.15** 0.13*** 0.82 0.82 214.14
(0.19) (0.04) (0.06) (0.06) (0.05)
Templeton Growth/Value 22 308.00$      -0.18 0.82*** 0.28*** 0.12 -0.15** 0.69 0.69 104.17
(0.24) (0.06) (0.08) (0.08) (0.06)
Weiss Blue Chip Div. Yield Value 12 168.00$      0.04 0.81*** 0.25*** 0.33*** -0.07 0.69 0.69 103.98
(0.24) (0.05) (0.08) (0.08) (0.06)
Stock Market Winners Growth/Value/Price MOM 12 168.00$      0.75* 0.49*** 0.50*** 0.32** 0.32*** 0.19 0.18 11.05
(0.46) (0.11) (0.15) (0.16) (0.12)
Note: Standard errors are shown in parentheses; * indicates significance at the 90% level, ** at 95%, and *** at 99%. Portfolios with statistically significant negative alphas are highlighted in red and portfolios 
with statistically significant positive alphas are highlighted in green. Transaction costs are calculated assuming 100% turnover rate and $7 fee per trade for a hypothetical $50,000 portfolio. 
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Appendix VI. Top Performers  
 
Top 10 Portfolios Outperforming the S&P 500 Top 10 Portfolios Outperforming the Best Fit Index
Piotroski: 9 Piotroski: 9 
Piotroski High F-Score Piotroski High F-Score
Est. Rev: Up 5 Est. Rev: Up 5 
Est. Rev. Top 30 Up Est. Rev. Top 30 Up
O'Shaughnessy Tiny Titans O'Shaughnessy Tiny Titans
MAGNET Simple O'Neil's CAN SLIM
O'Neil's CAN SLIM Graham Enterprising Investor Revised
Graham Enterprising Investor Revised Stock Market Winners
Price-to-Free Cash Flow Neff
Stock Market Winners Price-to-Free Cash Flow
Top 10 Portfolios Based on Sortino Ratios Top 10 Portfolios Based on Sharpe Ratios 
Piotroski: 9 Piotroski: 9 
MAGNET Complex Est. Rev: Up 5 
O'Neil's CAN SLIM Piotroski High F-Score
Kirkpatrick Growth Est. Rev. Top 30 Up
MAGNET Simple Value on the Move PEG With Est. Growth
Kirkpatrick Value Stock Market Winners
O'Neil's CAN SLIM Revised O'Shaughnessy Tiny Titans
Driehaus O'Neil's CAN SLIM
Foolish Small Cap 8 P/E Relative
Graham Enterprising Investor O'Shaughnessy Small Cap Growth and Value
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Top 10 - CAPM Alphas Top 10 - Three FactorAlphas 
Piotroski: 9 Piotroski: 9 
Piotroski High F-Score Piotroski High F-Score
O'Neil's CAN SLIM O'Neil's CAN SLIM
Est. Rev: Up 5 Est. Rev: Up 5 
O'Shaughnessy Tiny Titans Est. Rev. Top 30 Up
Est. Rev. Top 30 Up Stock Market Winners
Stock Market Winners O'Shaughnessy Tiny Titans
Graham Enterprising Investor Revised Graham Enterprising Investor Revised
Graham Enterprising Investor Graham Enterprising Investor
Price to Free Cash Flow Kirkpatrick Growth
Top 10 - Four Factor
Top Performers - Four Factor Model Adjusted 
for Transaction Costs 
Piotroski: 9 Piotroski: 9 
Piotroski High F-Score O'Neil's CAN SLIM
O'Neil's CAN SLIM Piotroski High F-Score
Est. Rev: Up 5 Graham Enterprising Investor Revised
Est. Rev. Top 30 Up Stock Market Winners
Stock Market Winners
Graham Enterprising Investor Revised
O'Shaughnessy Tiny Titans
Graham Enterprising Investor
Neff
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